Scaling down

Florescent probes mark chromosomal breakpoints in FISH-on-a-Chip. Credit: Courtesy of Linda Pilarski / University of Alberta" />Florescent probes mark chromosomal breakpoints in FISH-on-a-Chip. Credit: Courtesy of Linda Pilarski / University of Alberta User: Linda Pilarski, University of Alberta Project: Investigating chromosomal breaks and translocations in individual cells from patients with multiple myeloma. Problem: An ideal technique for t

Written byJosh P. Roberts
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

User:
Linda Pilarski, University of Alberta

Project:
Investigating chromosomal breaks and translocations in individual cells from patients with multiple myeloma.

Problem:
An ideal technique for tracking cancer treatment costs $500 to $1000 and is too time-consuming for routine use.

Solution:
In conventional interphase fluorescence in-situ hybridization (FISH), fluorescent probes flanking chromosomal break points are hybridized to whole cells on microscope slides; incorrect juxtaposition of the tags indicates an abnormality. Pilarski collaborated with engineer Chris Blackhouse to miniaturize the FISH assay and automate the analysis, dramatically reducing the amount of reagent and the time required.

What they designed was FISH on a chip: a single microfluidic device the size of a microscope slide in which cells can be adhered, porated, heated, and dried, hybridized with fluorescent probes, and then imaged by a standard microscope. The simplest version has ten channels for running ten tests on the same sample, thus using only ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies